The Northeast Node of the Clinical Trials Network sponsors an academic bimonthly Science Series on the state of the science on addiction and integrated care models, occurring during the lunch hour from 12:00 to 1:00 PM EST, and is open to all health and mental health professionals. Continuing Education credits are available for medical professionals (1.0 AMA PRA Category 1 Credits approved by Dartmouth-Hitchcock Medical Center) and clinical professionals (1.0 CEU from the Vermont Office of Professional Regulation for allied mental health, substance abuse counselors, social workers) who attend the interactive session.

If you have any questions about the Science Series or how to obtain Continuing Education credits, please email



Upcoming Webinars


Emergency Department Initiation of Alcohol Use Disorder Treatment

Javad Mashkuri, MD
April 25, 2024

Archived Webinars


Xylazine: Clinical Implications for People Who Use Drugs and Harm Mitigation Strategies

Ilana Hull, MD
March 14, 2024

Reverse integration: Partnerships to deliver primary care at community mental health centers for young adults with serious mental illness

Mary Brunette, MD
February 29, 2024

Exploring the intersection of SUD and suicide: Recent research and clinical implications

Peter Jongho Na, MD, MPH
October 26, 2023

Injectable XR Buprenorphine: A better mousetrap or a paradigm shift in MOUD?

Eva Quirion, NP, PhD
April 6, 2023

Treating Stimulant use Disorders in the Context of the Opioid Crisis: A Review

Craig R. Rush, PhD
February 9, 2023

Cannabis and Opioids: Promising pharmacology to address the opioid epidemic?

Ziva Cooper, PhD
November 17, 2022

Innovation in State-Level Drug Policies: Legalization, Decriminalization, and 24/7 Sobriety

Beau Kilmer, PhD
October 7, 2021

Injectable Extended-Release Buprenorphine Treatment in the Fentanyl Era

John Mariani, MD
March 11, 2021

Substance Use Coercion: Evidence and Implications

Carole Warshaw, MD and Gabriela Zapata-Alma, LCSW, CADC
February 4, 2021

Stimulant Use – Current Trends, Impact on the Brain, and Implications for Treatment and Recovery

Thomas E. Freese, PhD, and Beth Rutkowski, MPH
December 10, 2020

RAM: Vermont’s Rapid Access to Medication Assisted Treatment Project

Vermont RAM Team
November 12, 2020

Medication Formulation and Treatment Model Preferences Among People with Opioid Use Disorder

Elizabeth Saunders, PhD
October 1, 2020

Responding to the Opioid Epidemic's "Ripple Effect" through Integrated Family Care: The Policy and Payment Landscape

Suzanne Brundage
June 25, 2020

Vaping in 2020: Old Vices, New Devices

Dr. Susanne Tanski
February 13, 2020

New Hampshire’s Project FIRST (First Responders Initiating Recovery, Support, and Treatment)

Paula Holigan
November 7, 2019

Screening for substance use in primary care: An update on guidelines, screening tools, and strategies for addressing implementation barriers

Jennifer McNeely, MD, MS
September 12, 2019

Opioid pharmacotherapies for primary care and criminal justice populations: low threshold, low barrier approaches to naltrexone and buprenorphine treatments

Joshua D. Lee, MD
May 23, 2019

CTN-0068: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

Dr. Madhukar Trivedi
March 14, 2019

Using Project ECHO to Address the Opioid Epidemic in Rural Northern New England

Lisa Letourneau, MD, MPH, Jeanne Ryer, MSc, EdD
January 24, 2019

Parental Substance Misuse and Child Trauma

Kay Jankowski, PhD, and Erin Knight, PhD
November 15, 2018

What’s the Point? Harm Reduction through Syringe Exchange in White River Junction and Springfield, VT

Laura Byrne
September 27, 2018

Opioid Use Disorder and Commonly Co-occurring Conditions: An Infectious Disease Perspective

Kinna Thakarar, DO, MPH
May 24, 2018

Pharmacotherapy for Treating People with Alcohol Use Disorder

Mary Brunette, MD
March 29, 2018

Initiating Treatment for Opioid Use Disorder in the Emergency Department

Drs. Ryan McCormack and Kathryn Hawk
January 4, 2018

What’s age got to do with it? Addressing smoking in young adults with comorbidity

Mary Brunette, MD
November 16, 2017

Behavioral Sensing: An enabling technology for mobile health research

Emre Ertin, PhD
September 21, 2017

SBIRT in Primary Care Pediatrics: Lessons and Opportunities Beyond Implementation

Steven H. Chapman, MD
May 18, 2017

The Voices of New Hampshire Young Adults

Jill Burke, MPA and Rachel Kohn, MSW, MPH
March 30, 2017

Harnessing Digital Technologies in the Treatment of Substance Use Disorders

Lisa A. Marsch, PhD
January 26, 2017

The Safe Station Project

Christopher Hickey
November 10, 2016

Perinatal Substance Use Disorders: Rationale for Integrated Care

Daisy Goodman, CNM, DNP, MPH
September 29, 2016

Why Strategies to Integrate Behavioral Health in Primary Care Are Unsuccessful and What Can Be Done About It?

Mark P. McGovern, PhD
July 21, 2016

The Changing Landscape of Marijuana (Cannabis): What's Real and What's Not

Alan Budney, PhD
May 19, 2016

Interfaces of Pain & Addiction: Phenomenology, Clinical Care & Open Questions

Seddon Savage, MD, MS
March 4, 2016

Pharmacotherapy for Opioid Use Disorder

Tod Miller, MD
January 6, 2016